Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 2
1982 4
1983 6
1984 8
1985 5
1986 20
1987 12
1988 11
1989 14
1990 19
1991 13
1992 18
1993 14
1994 24
1995 27
1996 31
1997 35
1998 36
1999 33
2000 38
2001 42
2002 51
2003 65
2004 88
2005 110
2006 123
2007 142
2008 205
2009 239
2010 304
2011 348
2012 407
2013 424
2014 479
2015 570
2016 577
2017 657
2018 768
2019 839
2020 1056
2021 1244
2022 899
Text availability
Article attribute
Article type
Publication date

Search Results

8,920 results
Results by year
Filters applied: . Clear all
Page 1
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, Shen L, Shu Y, Wang C, Dai T, Mao T, Chen L, Guo Z, Liu B, Pan H, Cang S, Jiang Y, Wang J, Ye M, Chen Z, Jiang D, Lin Q, Ren W, Wang J, Wu L, Xu Y, Miao Z, Sun M, Xie C, Liu Y, Wang Q, Zhao L, Li Q, Huang C, Jiang K, Yang K, Li D, Liu Y, Zhu Z, Chen R, Jia L, Li W, Liao W, Liu HX, Ma D, Ma J, Qin Y, Shi Z, Wei Q, Xiao K, Zhang Y, Zhang Y, Chen X, Dai G, He J, Li J, Li G, Liu Y, Liu Z, Yuan X, Zhang J, Fu Z, He Y, Ju F, Liu Z, Tang P, Wang T, Wang W, Zhang J, Luo X, Tang X, May R, Feng H, Yao S, Keegan P, Xu RH, Wang F. Wang ZX, et al. Among authors: shi z. Cancer Cell. 2022 Mar 14;40(3):277-288.e3. doi: 10.1016/j.ccell.2022.02.007. Epub 2022 Mar 3. Cancer Cell. 2022. PMID: 35245446 Clinical Trial.
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, Qin JX, Wang GY, Zhang XM, Xia T, Liang Q, Zhao Y, Li R, Zhang SQ, Zhang JH, Chen JG, Wang GC, Chen ZS, Han CH. Shi ZD, et al. Mol Cancer. 2022 Feb 7;21(1):37. doi: 10.1186/s12943-022-01517-9. Mol Cancer. 2022. PMID: 35130920 Free PMC article.
Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth.
Zhao JS, Shi S, Qu HY, Keckesova Z, Cao ZJ, Yang LX, Yu X, Feng L, Shi Z, Krakowiak J, Mao RY, Shen YT, Fan YM, Fu TM, Ye C, Xu D, Gao X, You J, Li W, Liang T, Lu Z, Feng YX. Zhao JS, et al. Among authors: shi z. Nat Metab. 2022 Feb;4(2):239-253. doi: 10.1038/s42255-021-00524-2. Epub 2022 Feb 10. Nat Metab. 2022. PMID: 35145325
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
Wang CY, Hwang KP, Kuo HK, Peng WJ, Shen YH, Kuo BS, Huang JH, Liu H, Ho YH, Lin F, Ding S, Liu Z, Wu HT, Huang CT, Lee YJ, Liu MC, Yang YC, Lu PL, Tsai HC, Lee CH, Shi ZY, Liu CE, Liao CH, Chang FY, Chen HC, Wang FD, Hou KL, Cheng J, Wang MS, Yang YT, Chiu HC, Jiang MH, Shih HY, Shen HY, Chang PY, Lan YR, Chen CT, Lin YL, Liang JJ, Liao CC, Chou YC, Morris MK, Hanson CV, Guirakhoo F, Hellerstein M, Yu HJ, King CC, Kemp T, Heppner DG, Monath TP. Wang CY, et al. Among authors: shi zy. J Clin Invest. 2022 May 16;132(10):e157707. doi: 10.1172/JCI157707. J Clin Invest. 2022. PMID: 35316221 Free PMC article. Clinical Trial.
Incident-angle-insensitive toroidal metamaterial.
Li J, Shao J, Li X, Shi Z, Wang Y. Li J, et al. Among authors: shi z. Opt Express. 2022 Mar 14;30(6):8510-8516. doi: 10.1364/OE.453190. Opt Express. 2022. PMID: 35299302 Free article.
Zeolite NPO-Type Azolate Frameworks.
Zha X, Li X, Al-Omari AA, Liu S, Liang CC, Al-Ghourani A, Abdellatief M, Yang J, Nguyen HL, Al-Maythalony B, Shi Z, Cordova KE, Zhang YB. Zha X, et al. Among authors: shi z. Angew Chem Int Ed Engl. 2022 Jun 29:e202207467. doi: 10.1002/anie.202207467. Online ahead of print. Angew Chem Int Ed Engl. 2022. PMID: 35765853
Electrochemical Migratory Cyclization of N-Acylsulfonamides.
Shi Z, Li Y, Li N, Wang WZ, Lu HK, Yan H, Yuan Y, Zhu J, Ye KY. Shi Z, et al. Angew Chem Int Ed Engl. 2022 Jul 25;61(30):e202206058. doi: 10.1002/anie.202206058. Epub 2022 Jun 14. Angew Chem Int Ed Engl. 2022. PMID: 35606293
8,920 results